CCTCC Fair Market Value (FMV) Working Group (WG)

    CCTCC Fair Market Value (FMV) Working Group (WG)   On March 6th, representatives from several healthcare institutions and pharmaceutical companies met in Toronto

Read More »

Dr. Normand Blais appointed to the CRCHUM’s management team

  The board of directors of the CHUM Research Centre (CRCHUM) has announced the appointment of Dr. Normand Blais as Assistant Scientific Director of Clinical

Read More »

Oncopole: a research, development and investment hub to accelerate the fight against cancer

  Q-CROC welcomes the announcement of the creation of the Oncopole, born from a public-private partnership between the Fonds de recherche du Québec – Santé (FRQS)

Read More »

Canada's alliance for excellence in clinical research

From left to right: Thérèse Gagnon-Kugler (Q-CROC), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Stéphanie Ibrahim (CIUSSS du Nord-de-l’Île-de-Montréal),

Read More »

Sainte-Justine joins the Quebec clinical research network in oncology

  Q-CROC is pleased to welcome the CHU Sainte-Justine as the 11th member-institution of its clinical research network in oncology.   CHU Sainte-Justine has positioned itself

Read More »

Scientists have identify a DNA signature linked to prostate cancer severity

The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the a comprehensive genetic analysis of prostate cancer tumors in the journal Nature. This project

Read More »

50th liaison coordinators meeting

From left to right: Solange Tremblay (CISSS de Laval), Anne Brochu (CIUSSS de l’Estrie – CHUS), Claire Gagnon (CISSS du Bas-Saint-Laurent), Marie Saint-Jacques (CHU Sainte-Justine),

Read More »

Portfolio of clinical trials in oncology in Quebec and databases

  Through its role as network coordinator and clinical research development organization, Q-CROC has been able to collect a wide range of relevant evidence pertaining

Read More »

Clinical Development Success Rates

    The Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on the advantages of using biomarkers

Read More »

AstraZeneca launches integrated genomics approach to transform drug discovery and development

  AstraZeneca launches integrated genomics approach to transform drug discovery and development.   Read the press release: https://www.astrazeneca.com/media-centre/press-releases/2016/AstraZeneca-launches-integrated-genomics-approach-to-transform-drug-discovery-and-development-22042016.html#!

Read More »
Page1 Page2 Page3 Page4 Page5